Darrell & King’s Bristol-Myers Squibb BMY Stock Holding History

Darrell & King’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$335K	Hold	5,400	–	–	0.05%	31
2020 Q3	$326K	Hold	5,400	–	–	0.07%	28
2020 Q2	$318K	Sell	5,400 -1,001	-16%	-$59.9K	0.06%	32
2020 Q1	$357K	Buy	+6,401	New	+$391K	0.08%	27
2019 Q3	$274K	Hold	5,400	–	–	0.06%	40
2019 Q2	$245K	Sell	5,400 -934	-15%	-$43.5K	0.05%	46
2019 Q1	$302K	Hold	6,334	–	–	0.05%	44
2018 Q4	$329K	Hold	6,334	–	–	0.06%	39
2018 Q3	$393K	Sell	6,334 -1,250	-16%	-$74.2K	0.06%	36
2018 Q2	$420K	Hold	7,584	–	–	0.06%	35
2018 Q1	$480K	Hold	7,584	–	–	0.07%	33
2017 Q4	$465K	Hold	7,584	–	–	0.06%	33
2017 Q3	$483K	Hold	7,584	–	–	0.07%	34
2017 Q2	$423K	Sell	7,584 -1,030	-12%	-$56K	0.06%	34
2017 Q1	$468K	Buy	8,614 +2,280	+36%	+$125K	0.08%	31
2016 Q4	$370K	Hold	6,334	–	–	0.06%	36
2016 Q3	$342K	Buy	6,334 +834	+15%	+$53.6K	0.06%	37
2016 Q2	$405K	Sell	5,500 -1,228	-18%	-$86.8K	0.08%	32
2016 Q1	$430K	Buy	6,728 +1,228	+22%	+$77.4K	0.08%	33
2015 Q4	$378K	Buy	+5,500	New	+$363K	0.06%	37

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Darrell & King's BMY Position: Q4 2020 in Review

Darrell & King held its Bristol-Myers Squibb (BMY) position steady in Q4 2020 at 5,400 shares worth $335K. The position accounts for 0.05% of the portfolio, ranked #31.

Darrell & King first reported a position in BMY in Q4 2015 and has held it in 20 quarters since. The position peaked at $483K in Q3 2017. 2,360 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

Darrell & King held 5,400 shares of Bristol-Myers Squibb worth $335K as of Q4 2020.
Darrell & King left its Bristol-Myers Squibb share count unchanged in Q4 2020.
Bristol-Myers Squibb made up 0.05% of Darrell & King's portfolio in Q4 2020, its #31 holding.
Darrell & King first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 20 quarters since.
Darrell & King's Bristol-Myers Squibb position peaked at $483K in Q3 2017.
2,360 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Darrell & King's 13F filing for Q4 2020, filed 15 Jan 2021.